Tablet

Pioglitazone 30mg

Pioglitazone Hydrochloride

PPAR-gamma agonist thiazolidinedione that improves insulin sensitivity in peripheral tissues — muscle, fat, and liver — and favorably modifies lipid profiles by increasing HDL and reducing triglycerides. Uniquely addresses the underlying insulin resistance pathophysiology of type 2 diabetes and is widely used in combination regimens across Asia and Africa.

Strengths

15mg / 30mg / 45mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request Quotation WhatsApp

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition

Pioglitazone Hydrochloride 15mg / 30mg / 45mg

Dosage Form

Tablet

Available Strengths

15mg / 30mg / 45mg

Packing

10 tablets/strip

Route of Administration

Oral, with or without food

Dosage

15-30mg once daily initially; may increase to max 45mg once daily; lower doses if combined with insulin

Indications

Type 2 diabetes mellitus (as monotherapy or in combination with metformin, sulfonylurea, or insulin)

Country of Origin

India (WHO-GMP Certified)

Storage

Store at 25°C, protected from moisture and light

Shelf Life

36 months

Side Effects

Edema, weight gain, upper respiratory infection, headache, bone fractures (women), bladder cancer risk (prolonged use)

Precautions

Contraindicated in heart failure (NYHA Class III/IV); bladder cancer risk with >1 year use; monitor for edema and weight gain; liver function tests; not for type 1 diabetes; may cause or worsen CHF

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Tablet

Glimepiride 2mg

Glimepiride

Third-generation sulfonylurea that stimulates pancreatic beta-cell insulin secretion via selective SUR1 receptor binding, offering a lower hypoglycemia risk compared to earlier sulfonylureas due to glucose-dependent activity. The most cost-effective oral antidiabetic agent in its class and a cornerstone of type 2 diabetes management in emerging markets.

1mg / 2mg / 3mg / 4mg

Tablet

Sitagliptin 100mg

Sitagliptin Phosphate

First-in-class DPP-4 inhibitor that amplifies incretin-mediated glucose-dependent insulin secretion while suppressing glucagon, offering glycemic control without weight gain or intrinsic hypoglycemia risk. Once-daily dosing, renal dose adjustment flexibility, and a decade-long cardiovascular safety record make it a globally preferred add-on antidiabetic.

25mg / 50mg / 100mg

Tablet

Vildagliptin 50mg

Vildagliptin

Selective DPP-4 inhibitor with potent enzyme inhibition that improves glycemic control through enhanced incretin-mediated insulin secretion and suppressed post-meal glucagon release. Widely prescribed as a fixed-dose combination with metformin (Galvusmet) offering convenient dual-mechanism therapy without weight gain.

50mg

Need bulk pricing for Pioglitazone 30mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote